Anti-Inflammatory & Antibiotic Eye Ointment Franchise in Ahmedabad

Polyflip Plus Eye Ointment Supplier in Mumbai

Steroid-Antibiotic Eye Ointment Distributor in Delhi

Ophthalmic Therapy PCD Pharma Franchise in Bangalore

Polyflip Plus Eye Ointment Stockist in Hyderabad
Anti-Inflammatory & Antibiotic Eye Ointment Manufacturer & Exporter in Chandigarh

Home/Products /polymyxin-b-5000iu-chloramphenicol-1-betamethasone-0-1-eye-ointment

Polyflip Plus Eye Ointment

Composition : Polymyxin B (5000IU) + Chloramphenicol (1%) + Betamethasone (0.1%) Eye Ointment

Dosage Form : Eye Ointment

Packaging Type : Tube

Packaging : 5gm

Price : ₹0/-

Polyflip Plus Eye Ointment contains Polymyxin B 5000 IU + Chloramphenicol 1% + Betamethasone 0.1%, a steroid-antibiotic ophthalmic ointment designed for bacterial eye infections associated with inflammation.

It works by eliminating bacterial pathogens while reducing redness, swelling, and irritation, providing fast-acting relief from ocular discomfort. The combination of antibiotics and anti-inflammatory steroid ensures comprehensive treatment of infected and inflamed eyes.

Clinically, Polyflip Plus Eye Ointment is suitable for conjunctivitis, blepharitis, keratitis, and post-surgical inflammatory infections, offering prolonged contact and enhanced therapeutic efficacy due to its ointment base.

From a business perspective, Polyflip Plus Eye Ointment occupies a strong position in the steroid-antibiotic therapy segment, widely used in eye clinics, hospitals, and specialty practices, ensuring consistent prescription demand and repeat usage, making it a reliable and profitable ophthalmic product.

Read More

About the Product

Polyflip Plus Eye Ointment contains Polymyxin B 5000 IU + Chloramphenicol 1% + Betamethasone 0.1%, a steroid-antibiotic ophthalmic ointment designed for bacterial eye infections associated with inflammation.

It works by eliminating bacterial pathogens while reducing redness, swelling, and irritation, providing fast-acting relief from ocular discomfort. The combination of antibiotics and anti-inflammatory steroid ensures comprehensive treatment of infected and inflamed eyes.

Clinically, Polyflip Plus Eye Ointment is suitable for conjunctivitis, blepharitis, keratitis, and post-surgical inflammatory infections, offering prolonged contact and enhanced therapeutic efficacy due to its ointment base.

From a business perspective, Polyflip Plus Eye Ointment occupies a strong position in the steroid-antibiotic therapy segment, widely used in eye clinics, hospitals, and specialty practices, ensuring consistent prescription demand and repeat usage, making it a reliable and profitable ophthalmic product.

Common side effects may include temporary blurred vision, mild burning or stinging, eye irritation, or redness. Rarely, hypersensitivity reactions, delayed wound healing, or increased intraocular pressure may occur with prolonged use.

Polyflip Plus Eye Ointment is indicated for the treatment of bacterial eye infections with associated inflammation, including conjunctivitis, keratitis, blepharitis, and other steroid-responsive ocular inflammatory conditions caused or complicated by susceptible bacteria.

Use Polyflip Plus Eye Ointment strictly as prescribed by an ophthalmologist. Avoid touching the tube tip to the eye or any surface to prevent contamination. Do not use in viral or fungal eye infections unless prescribed with appropriate therapy. Complete the full course as directed and discontinue if severe irritation or allergic reaction occurs.

Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the tube tightly closed, and out of reach of children. Do not use beyond the expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation